Nascent Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
For the nine months, net loss was USD 0.063783 million compared to USD 1.34 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0889 USD | 0.00% | -1.11% | -48.58% |
1st Jan change | Capi. | |
---|---|---|
-48.58% | 15.17M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |